Related Experiment Video
Updated: Jul 1, 2025
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
13.8K
RNA therapeutics for infectious diseases.
Le Minh Tu Phan1, Thi Thuy Duong Pham2, Van Thai Than3
1School of Medicine and Pharmacy, The University of Danang, Danang, Vietnam.
Progress in Molecular Biology and Translational Science
|March 8, 2024
Summary
RNA therapeutics, particularly messenger RNA (mRNA) vaccines, offer promising prophylactic and therapeutic strategies for infectious diseases in humans and animals. This review highlights their current applications and potential.
Area of Science:
- Molecular Biology
- Immunology
- Biotechnology
Background:
- Ribonucleic acids (RNAs) like messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA) are fundamental to life in organisms and viruses.
- RNA-based technologies are emerging as powerful tools in medicine.
- These technologies include RNA interference, protein targeting, genetic reprogramming, and therapeutic protein production.
Approach:
- This review synthesizes current research on RNA therapeutics.
- It specifically focuses on the application of messenger RNA (mRNA) vaccines.
- The review examines their potential in preventing and treating infectious diseases.
Key Points:
- RNA therapeutics encompass diverse applications such as inhibiting RNA activity and targeting proteins.
- Messenger RNA (mRNA) vaccines represent a significant advancement in vaccine technology.
- RNA-based approaches are being developed for both prophylactic and therapeutic purposes.
Conclusions:
- RNA therapeutics, especially mRNA vaccines, show considerable potential for combating infectious diseases.
- Further development in RNA technology could revolutionize vaccine development and treatment strategies.
- The review underscores the growing importance of RNA in modern medicine and disease prevention.
Related Concept Videos
01:23Types of RNA
63.7K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.7K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K